Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.
We report on a woman with idiopathic Meige's syndrome whose dystonia improved with the use of levetiracetam (LEV, Keppra, UCB Pharma, Smyrna, GA). This report and data from an animal model of paroxysmal dystonia suggest that LEV might be helpful in the treatment of dystonia.
Zesiewicz
Theresa A
TA
Parkinson's Disease and Movement Disorders Center, University of South Florida, Tampa, Florida, USA. tzesiewi@hsc.usf.edu
Louis
Elan D
ED
Sullivan
Kelly L
KL
Menkin
Martin
M
Dunne
Peter B
PB
Hauser
Robert A
RA
D000927:Anticonvulsants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008538:Meige Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000927:Anticonvulsants; D000077287:Levetiracetam; D010889:Piracetam